MicroRNA ‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)

ConclusionsIntegrating biomarkers across different body fluids would synergistically improve the early detection of NSCLC.Key points
Lung cancer is a heterogeneous disease and develops from complex aberrations.
Integrating sputum and plasma miRNAs has higher accuracy than when they are used alone

Source: Thoracic Cancer - January 27, 2020 Category: Cancer & Oncology Authors: Jipei Liao, Jun Shen, Qixin Leng, Meng Qin, Min Zhan, Feng Jiang Tags: ORIGINAL ARTICLE Source Type: research